SiliconANGLE: Otter.ai raises $320M in funding for its AI meeting assistant
Otter.ai Inc., the developer of a popular artificial intelligence meeting assistant, today announced that it has raised $320 million in funding. The capital came entirely from General Catalyst’s Customer Value Fund. The investment vehicle provides startups with financing for sales and marketing initiatives. General Catalyst doesn’t take a stake in portfolio companies, but instead receives […] The post Otter.ai raises $320M in funding for its AI meeting assistant appeared first on SiliconAN
Part of a story that several outlets report: Otter.ai raises $320 million for meeting assistant growth
Otter.ai, a developer of an AI meeting assistant, raised $320 million in funding from General Catalyst's Customer Value Fund, which finances sales and marketing rather than taking ownership stakes in companies. The platform transcribes meetings using AI-powered speaker recognition, generates summaries with action items, and provides role-specific tools for salespeople, teachers, and other users, while integrating with external services like HubSpot, Slack, and ChatGPT. The company currently has over 40 million users worldwide, including employees at more than 86 percent of Fortune 500 companies, and plans to double its enterprise business by tripling its sales and marketing budget over the next year.
Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.
Browse AI courses on Maven
Should OpenAI command an over $1 trillion valuation with this round, it would break records as the most highly valued private company ever.
Also reported by SiliconANGLE

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Also reported by TechCrunch, SiliconANGLE and The Decoder

DeepSeek has reportedly raised $15 billion in one of China's largest funding rounds, just days after the US ordered federal agencies to remove its technology over national security concerns.
Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. Pathos’ investor roster includes big names such as AstraZeneca plc, NEA and General Atlantic. Pathos is developing cancer drugs […] The post AI drug development startup Pathos AI closes $237M investment appeared first on SiliconANGLE.

Meta says it's issuing a new class of shares to fund its AI initiatives. As part of its third-quarter earnings report released on Wednesday, the company says the non-voting stock will also go toward potential acquisitions and employee compensation, with trading beginning in 2027. "The scale of investment required to compete, sustain growth, expand infrastructure, and pursue new strategic initiatives amidst the AI transformation taking place in the industry is significant," Meta
Also reported by TechCrunch
Artificial intelligence research lab Flapping Airplanes Inc. today announced it has raised $1 billion in new funding, about a year after it was founded. Investors valued the startup at $6 billion in the deal, Bloomberg reported. No commercial product has come out of the lab yet. Flapping Airplanes is trying to build AI models that […] The post Year-old AI research lab Flapping Airplanes raises $1B at a reported $6B valuation appeared first on SiliconANGLE.